You are now leaving Twirla.com/hcp
and being directed to the website for
Sterling Specialty Pharmacy

Patient support

Helping your
patient with her Twirla® prescription

Patch Replacement &
Nurse Educator Support

Your patient may want to talk to a nurse educator or require a replacement patch prior to the prescription refill date for many different reasons. If that happens, we can ship a new patch to your patient at no additional out-of-pocket cost and with no new prescription required if refills are remaining.*

LEARN MORE

Twirla
Savings Program

The Twirla Savings Program offers your patient with commercial insurance and a required copay the chance to reduce out-of-pocket costs.

LEARN MORE

Sample Letter of
Medical Necessity

If your patient is not covered or if she has a plan with a high deductible, her insurance provider may require a letter of medical necessity to assist in securing coverage with no copayment.

DOWNLOAD

Sterling Specialty
Pharmacy

Sterling Specialty Pharmacy can help patients arrange for home delivery of their Twirla prescriptions. They can also help patients with other prescription hurdles like completing the benefits investigation process, obtaining prior authorization, managing the appeals process, and completing mandated pharmacy transfers. For more information, visit sterlingspecialtyrx.com.

ENROLLMENT FORM

*Program limitations apply, including a limit on the number of replacement patches available per patient. Agile Therapeutics, Inc. reserves the right to change the terms of the program at any time without notice.

IMPORTANT SAFETY INFORMATION

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI ≥30 kg/m2

Cigarette Smoking and Serious Cardiovascular Events

Cigarette smoking increases the risk of serious cardiovascular events from combined hormonal contraceptive (CHC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, CHCs, including TWIRLA, are contraindicated in women who are over 35 years of age and smoke.

Contraindicated in Women with a BMI ≥30 kg/m2

TWIRLA is contraindicated in women with a BMI ≥30 kg/m2. Compared to women with a lower BMI, women with a BMI ≥30 kg/m2 had reduced effectiveness and may have a higher risk for venous thromboembolic events (VTEs).